ArticleBMC women's health2025
Facilitating gynecological examination and long acting reversible contraception for women with substance use disorder: a prospective cohort study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Perinatal Insights Into Parenting, Pathways, and Addiction (PIPPA): Protocol for a Longitudinal, Strengths-Based Study in Flanders, Belgium.JMIR research protocols · 2026Article
- Perspectives of professionals on the perinatal period as a window of opportunity for change in women with SUD: insights from healthcare, child welfare, substance use, and child protection services.Frontiers in psychiatry · 2026Article
- Barriers, beliefs, and biomedical prevention: a qualitative study of PrEP among justice-involved peripregnant women who use drugs.Health & justice · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWomen with substance use disorder (SUD) face a higher risk of sexual assault, abuse, cervical premalignant lesions, and unplanned pregnancy compared to the general female population. To meet the specific needs of this vulnerable group, we established a comprehensive gynecological service. The study aimed to describe the characteristics of women with SUD who accessed these services. Furthermore, we evaluated their cervical cytology and sexually transmitted infections (STIs) test results, preferred contraceptive methods, and the overall acceptability of the service.
methodsWe enrolled 48 women undergoing outpatient or inpatient treatment for SUD in the South-Trøndelag region of Norway in the study. Each women received a comprehensive gynecological anamnesis, including a history of sexual assault, followed by a gynecological examination at the outpatient clinic of the Department of Obstetrics and Gynecology. The examination included ThinPrep Tests and microbiological swabs. They were also offered contraception options, with an emphasis on Long Acting Reversible Contraceptives (LARC), at no cost. Participants provided feedback on the service immediately after their consultation and again six months later.
resultsNearly two-thirds (63%) of the women with a mean age 31.8, reported a history of sexual assault. One in three (33%) had cervical cytology or human pappilomavirus (HPV) test results necessitating treatment or follow-up, though no cases of sexually transmitted infections were found. Two thirds (66%) of eligible women chose LARC as their contraceptive method. Among the 23 women reached for a follow-up phone call six months later, all expressed high level of satisfaction with the service and indicated they would recommend it to other women in similar situations.
conclusionsAn integrated, specialized gynecological service that provides cervical testing and contraceptive counselling can effectively reach women receiving outpatient or inpatient treatment for SUD, who typically fail to follow-up routine women's health screening programmes. If implemented, this approach has the potential to reduce unplanned pregnancies and improve early detection of cervical pathology in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.